Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ceapro Inc (CRPOF)

Ceapro Inc (CRPOF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 40,356
  • Shares Outstanding, K 77,608
  • Annual Sales, $ 9,710 K
  • Annual Income, $ -850 K
  • 60-Month Beta 1.98
  • Price/Sales 4.14
  • Price/Cash Flow N/A
  • Price/Book 2.29
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/26/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3795 +37.02%
on 07/15/20
0.5773 -9.93%
on 07/21/20
+0.1361 (+35.45%)
since 07/14/20
3-Month
0.1920 +170.83%
on 05/20/20
0.5773 -9.93%
on 07/21/20
+0.3155 (+154.28%)
since 05/13/20
52-Week
0.1125 +362.22%
on 03/19/20
0.5773 -9.93%
on 07/21/20
+0.2330 (+81.18%)
since 08/14/19

Most Recent Stories

More News
Ceapro Inc. Announces Publication of Positive Results from Study Evaluating Avenanthramides in Exercise-Induced Inflammation

Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CRPOF : 0.5200 (+0.48%)
Ceapro Announces Results of 2020 Shareholders' Meeting

Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CRPOF : 0.5200 (+0.48%)
Ceapro Inc. Announces Publication of Positive Results for a PGX Processed Drug Delivery System for Accelerated Burn Wound Healing

- Results from successful drug-impregnation of PGX liquid processed alginate hydrogel scaffolds further bolsters Ceapro's efforts to develop innovative delivery systems composed of new chemical complexes...

CRPOF : 0.5200 (+0.48%)
Ceapro Inc. to Present at the Virtual Investor Fireside Chat Series

Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CRPOF : 0.5200 (+0.48%)
Ceapro Inc. Reports 2020 First Quarter Financial Results and Highlights

- Maintained production operations during COVID-19 pandemic crisis, providing our customers essential products while ensuring the health and safety of our employees -

CRPOF : 0.5200 (+0.48%)
CZO.VN : 0.680 (-1.45%)
Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19

- New project seeks to expand on positive preliminary results from ongoing research program with McMaster University to develop innovative drug delivery systems using disruptive PGX Technology

CRPOF : 0.5200 (+0.48%)
CZO.VN : 0.680 (-1.45%)
Ceapro Inc. Reports Fourth Quarter and Full Year 2019 Results and Highlights

Ceapro Inc. (TSX-V: CZO, OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CRPOF : 0.5200 (+0.48%)
Ceapro Inc. to Present at the April 2020 Virtual Investor Summit

Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CRPOF : 0.5200 (+0.48%)
Ceapro Inc. Receives Research License from Health Canada Controlled Substances and Cannabis Branch

Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CRPOF : 0.5200 (+0.48%)
Ceapro Inc. to Present at Noble Capital Markets' 16th Annual Investor Conference

Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CRPOF : 0.5200 (+0.48%)
Trade CRPOF with:

Key Turning Points

2nd Resistance Point 0.5268
1st Resistance Point 0.5234
Last Price 0.5200
1st Support Level 0.5183
2nd Support Level 0.5166

See More

52-Week High 0.5773
Last Price 0.5200
Fibonacci 61.8% 0.3997
Fibonacci 50% 0.3449
Fibonacci 38.2% 0.2901
52-Week Low 0.1125

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar